DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Technetium tc-99m medronate kitis the generic ingredient in five branded drugs marketed by Ge Healthcare, Pharmalucence, and Cardinal Health 414, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.
There are four drug master file entries for technetium tc-99m medronate kit. One supplier is listed for this compound.
Recent Clinical Trials for technetium tc-99m medronate kit
Identify potential brand extensions & 505(b)(2) entrants
|University of Utah||Phase 2|
|University of Manitoba||Phase 3|
|Winnipeg Regional Health Authority||Phase 3|
Pharmacology for technetium tc-99m medronate kit
|Drug Class||Radioactive Diagnostic Agent |
|Mechanism of Action||Radiopharmaceutical Activity |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Ge Healthcare||TECHNETIUM TC 99M MPI MDP||technetium tc-99m medronate kit||INJECTABLE;INJECTION||018141-002||Jun 12, 1989||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Pharmalucence||OSTEOLITE||technetium tc-99m medronate kit||INJECTABLE;INJECTION||017972-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Pharmalucence||CIS-MDP||technetium tc-99m medronate kit||INJECTABLE;INJECTION||018124-001||Approved Prior to Jan 1, 1982||RX||No||No||Start Trial||Start Trial||Start Trial|
|Ge Healthcare||TECHNETIUM TC 99M MPI MDP||technetium tc-99m medronate kit||INJECTABLE;INJECTION||018141-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Cardinal Health 414||MDP-BRACCO||technetium tc-99m medronate kit||INJECTABLE;INJECTION||018107-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Ge Healthcare||AMERSCAN MDP KIT||technetium tc-99m medronate kit||INJECTABLE;INJECTION||018335-001||Aug 5, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.